{{Rsnum
|rsid=2195239
|Gene=IGF1
|Chromosome=12
|position=102462924
|Orientation=minus
|GMAF=0.3287
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=IGF1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 6.2 | 29.2 | 64.6
| HCB | 13.3 | 46.7 | 40.0
| JPT | 17.8 | 48.9 | 33.3
| YRI | 14.3 | 50.8 | 34.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.3 | 46.7 | 40.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21562710
|Title=Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women
}}{{PMID|17300730|OA=1
}} Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.

{{PMID|18199734|OA=1
}} IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.

{{PMID|18596909|OA=1
}} IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

{{PMID|19124510|OA=1
}} Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.

{{PMID|19551864|OA=1
}} Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.

{{PMID|21047277}} Polymorphisms of insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) contribute to pathologic progression in childhood IgA nephropathy.

{{PMID|21690232}} Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy.{{PMID Auto
|PMID=23800627
|Title=Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial.
}}